Multisystem Inflammatory Syndrome (MIS) following SARS-CoV-2 vaccinations; a systematic review
Tóm tắt
Although SARS-CoV-2 vaccines are generally safe, there are growing concerns about their link to a potentially life-threatening multi-system inflammatory syndrome following vaccination (MIS-V). We conducted this systematic review to elucidate the prevalence of MIS, severity, treatment, and outcomes following SARS-CoV-2 vaccination. We searched PubMed, Scopus, ScienceDirect, Google Scholar, Virtual Health Library (VHL), Cochrane Library, and Web of Science databases for articles and case reports about MIS-V. We performed a qualitative analysis of individual cases from the included studies. Of the 1366 studies identified by database search, we retrieved twenty-six case reports and two cohort studies. We analyzed the data of 37 individual cases extracted from 27 articles. The average age of the cases included in this review was 18 (1–67) years, with the most being male (M: F 3.1:1). Of the 37 included cases, the cardiovascular system was the most affected system by MIS (36, 97.3%), followed by the gastrointestinal tract (32, 86.5%). MIS after SARS-CoV-2 vaccinations can be fatal, but the incidence is low. Prompt recognition of MIS and ruling out the mimickers are critical in the patient’s early recovery.
Tài liệu tham khảo
Mathieu E, Ritchie H, Rodés-Guirao L, et al. Coronavirus Pandemic (COVID-19). Our World Data. Published online March 5, 2020, 2023. https://ourworldindata.org/coronavirus. Accessed June 18
Polack FP, Thomas SJ, Kitchin N, et al. Safety and Efficacy of the BNT162b2 mRNA Covid-19 Vaccine. N Engl J Med. 2020;383(27):2603–15. https://doi.org/10.1056/NEJMoa2034577.
Walsh EE, Frenck RW, Falsey AR, et al. Safety and Immunogenicity of Two RNA-Based Covid-19 Vaccine Candidates. N Engl J Med. 2020;383(25):2439–50. https://doi.org/10.1056/NEJMoa2027906.
Remmel A. COVID vaccines and safety: what the research says. Nature. 2021;590(7847):538–40.
Rahman MM, Masum MHU, Wajed S, Talukder A. A comprehensive review on COVID-19 vaccines: development, effectiveness, adverse effects, distribution and challenges. Virusdisease. Published online February 1, 2022:1–22. https://doi.org/10.1007/s13337-022-00755-1
Newburger E. FDA adds warning about rare heart inflammation to Pfizer, Moderna Covid vaccines. CNBC. Published June 26, 2021. https://www.cnbc.com/2021/06/26/fda-adds-warning-of-rare-heart-inflammation-to-pfizer-moderna-vaccines.html. Accessed July 16, 2023
Whittaker E, Bamford A, Kenny J, et al. Clinical characteristics of 58 children with a pediatric inflammatory multisystem syndrome temporally associated with SARS-CoV-2. JAMA. 2020;324(3):259–69. https://doi.org/10.1001/jama.2020.10369.
Godfred-Cato S, Bryant B, Leung J, et al. COVID-19-associated multisystem inflammatory syndrome in children - United States, March-July 2020. MMWR Morb Mortal Wkly Rep. 2020;69(32):1074–80. https://doi.org/10.15585/mmwr.mm6932e2.
Gupta A, Gill A, Sharma M, Garg M. Multi-system inflammatory syndrome in a child mimicking kawasaki disease. J Trop Pediatr. 2021;67(3):fmaa060. https://doi.org/10.1093/tropej/fmaa060.
Morris SB, Schwartz NG, Patel P, et al. Case series of multisystem inflammatory syndrome in adults associated with SARS-CoV-2 Infection - United Kingdom and United States, March-August 2020. MMWR Morb Mortal Wkly Rep. 2020;69(40):1450–6. https://doi.org/10.15585/mmwr.mm6940e1.
Vogel TP, Top KA, Karatzios C, et al. Multisystem inflammatory syndrome in children and adults (MIS-C/A): Case definition & guidelines for data collection, analysis, and presentation of immunization safety data. Vaccine. 2021;39(22):3037–49. https://doi.org/10.1016/j.vaccine.2021.01.054.
Payne AB, Gilani Z, Godfred-Cato S, et al. Incidence of Multisystem Inflammatory Syndrome in Children Among US Persons Infected With SARS-CoV-2. JAMA Netw Open. 2021;4(6):e2116420–e2116420. https://doi.org/10.1001/jamanetworkopen.2021.16420.
La Torre F, Elicio MP, Monno VA, et al. Incidence and Prevalence of Multisystem Inflammatory Syndrome in Children (MIS-C) in Southern Italy. Children. 2023;10(5). https://doi.org/10.3390/children10050766
Belay ED, Godfred Cato S, Rao AK, et al. Multisystem Inflammatory Syndrome in Adults After Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Infection and Coronavirus Disease 2019 (COVID-19) Vaccination. Clin Infect Dis Off Publ Infect Dis Soc Am. Published online November 28, 2021:ciab936. https://doi.org/10.1093/cid/ciab936
Nune A, Iyengar KP, Goddard C, Ahmed AE. Multisystem inflammatory syndrome in an adult following the SARS-CoV-2 vaccine (MIS-V). BMJ Case Rep. 2021;14(7). https://doi.org/10.1136/bcr-2021-243888
JBI Critical Appraisal Tools | JBI. https://jbi.global/critical-appraisal-tools. Accessed July 16, 2023
Joshi S, Bhatia A, Tayal N, Jha LK, Gupta P. Rare Multisystem Inflammatory Syndrome in Young Adult after COVID-19 Immunization and Subsequent SARSCoV-2 Infection. J Assoc Physicians India. 2022;69(12):11–2.
Yalçinkaya R, Öz FN, Polat M, et al. A Case of Multisystem Inflammatory Syndrome in a 12-Year-old Male After COVID-19 mRNA Vaccine. Pediatr Infect Dis J. 2022;41(3):e87–9. https://doi.org/10.1097/INF.0000000000003432.
DeJong J, Sainato R, Forouhar M, Robinson D, Kunz A. multisystem inflammatory syndrome in a previously vaccinated adolescent female with sickle cell disease. Pediatr Infect Dis J. 2022;41(3):e104–5. https://doi.org/10.1097/INF.0000000000003444.
Abdelgalil AA, Saeedi FA. Multisystem Inflammatory Syndrome in a 12-Year-old Boy After mRNA-SARS-CoV-2 Vaccination. Pediatr Infect Dis J. 2022;41(3):e93–4. https://doi.org/10.1097/INF.0000000000003442.
Hugh McGann P, Krim AOA, Green J, Venturas J. Multi inflammatory syndrome in a 16-year-old male following first dose of m-RNA COVID-19 vaccination. Clin Infect Pract. 2022;14:100139. https://doi.org/10.1016/j.clinpr.2022.100139.
Miyazato Y, Yamamoto K, Yamada G, et al. Multisystem Inflammatory Syndrome in Adult after First Dose of mRNA Vaccine. Emerg Infect Dis. 2022;28(4):870–2. https://doi.org/10.3201/eid2804.212585.
Choi YK, Moon JY, Kim J, et al. Postvaccination multisystem inflammatory syndrome in adult with no evidence of prior SARS-CoV-2 infection. Emerg Infect Dis. 2022;28(2):411–4. https://doi.org/10.3201/eid2802.211938.
Bova C, Vigna E, Gentile M. Multisystem Inflammatory Syndrome after Ad26.COV2.S vaccination. IDCases. 2022;27:e01411. https://doi.org/10.1016/j.idcr.2022.e01411.
Chai Q, Nygaard U, Schmidt RC, Zaremba T, Møller AM, Thorvig CM. Multisystem inflammatory syndrome in a male adolescent after his second Pfizer-BioNTech COVID-19 vaccine. Acta Paediatr Oslo Nor 1992. 2022;111(1):125–7. https://doi.org/10.1111/apa.16141.
Poussaint TY, LaRovere KL, Newburger JW, et al. Multisystem inflammatory-like syndrome in a child following COVID-19 mRNA vaccination. Vaccines. 2021;10(1):43. https://doi.org/10.3390/vaccines10010043.
Lee S, Ardoin SP, Blaney C, et al. Multisystem inflammatory syndrome in children after breakthrough infection in a COVID-19-vaccinated child. Pediatr Infect Dis J. 2022;41(4):e182–3. https://doi.org/10.1097/INF.0000000000003451.
Al Bishawi A, Ali M, Al-Zubaidi K, Abdelhadi H. Beware of the ambiguous enemy of multisystem inflammatory syndrome in adult (MIS-A) following Covid-19 infection or vaccination. Clin Case Rep. 2021;9(11):e05138. https://doi.org/10.1002/ccr3.5138.
Park JW, Yu SN, Chang SH, Ahn YH, Jeon MH. Multisystem inflammatory syndrome in an adult after COVID-19 vaccination: a case report and literature review. J Korean Med Sci. 2021;36(45):e312. https://doi.org/10.3346/jkms.2021.36.e312.
Buchhorn R, Meyer C, Schulze-Forster K, Junker J, Heidecke H. Autoantibody release in children after corona virus mRNA vaccination: a risk factor of multisystem inflammatory syndrome? Vaccines. 2021;9(11):1353. https://doi.org/10.3390/vaccines9111353.
Uwaydah AK, Hassan NMM, Ghoush MSA, Shahin KMM. Adult multisystem inflammatory syndrome in a patient who recovered from COVID-19 postvaccination. BMJ Case Rep CP. 2021;14(4):e242060. https://doi.org/10.1136/bcr-2021-242060.
Agarwal AK, Lamba B, Kumari V, Kaushik A, Chaudhary A, Gadpayle AK. Covid-19-related multisystem inflammatory syndrome in adults: An uncommon case. J Indian Acad Clin Med. 2021;22(3-4):147–50.
Bangash B, Pitcher J, Makki I. Multisystem inflammatory syndrome in children and adolescents (MIS-C) in a young adult with recent vaccination. Chest. 2021;160(4):A660. https://doi.org/10.1016/j.chest.2021.07.627.
Deb A, Abdelmalek J, Iwuji K, Nugent K. Acute myocardial injury following COVID-19 vaccination: a case report and review of current evidence from vaccine adverse events reporting system database. J Prim Care Community Health. 2021;12:21501327211029230. https://doi.org/10.1177/21501327211029230.
Salzman MB, Huang CW, O’Brien CM, Castillo RD. Multisystem inflammatory syndrome after SARS-CoV-2 infection and COVID-19 vaccination. Emerg Infect Dis. 2021;27(7):1944–8. https://doi.org/10.3201/eid2707.210594.
Koga T, Yoshimura M, Kubo S, et al. Multisystem Inflammatory Syndrome after COVID-19 Vaccination (MIS-V) Presenting with Retropharyngeal Phlegmon in a 15-year-old Boy in Japan. Am J Med Case Rep. 2022;10(2):35–8. https://doi.org/10.12691/ajmcr-10-2-4.
Lieu A, Mah J, Church D. A case of multisystem inflammatory syndrome in adults following natural infection and subsequent immunization. Int J Infect Dis IJID Off Publ Int Soc Infect Dis. 2022;116:34–7. https://doi.org/10.1016/j.ijid.2021.12.339.
Baicus C, Delcea C, Pinte L, Dan GA. Hyper-inflammation after COVID-19 mARN vaccination: at the crossroads of multisystem inflammatory disease and adult-onset Still’s disease. Does terminology matter? Romanian J Intern Med Rev Roum Med Interne. 2022;60(1):3–5. https://doi.org/10.2478/rjim-2021-0035.
Kahn B, Apostolidis SA, Bhatt V, et al. Multisystem Inflammation and Organ Dysfunction After BNT162b2 Messenger RNA Coronavirus Disease 2019 Vaccination. Crit Care Explor. 2021;3(11):e0578.:https://doi.org/10.1097/CCE.0000000000000578
Taneja V, Khosla P. Post vaccination -Multisystemic inflammatory syndrome -adults. Ann Clin Med Case Rep. 2021;7(5):1–2.
Grome HN, Threlkeld M, Threlkeld S, et al. Fatal Multisystem Inflammatory Syndrome in Adult after SARS-CoV-2 Natural Infection and COVID-19 Vaccination. Emerg Infect Dis. 2021;27(11):2914–8. https://doi.org/10.3201/eid2711.211612.
Ouldali N, Bagheri H, Salvo F, et al. Multisystemic inflammatory syndrome following COVID-19 mRNA vaccine in children: a national post-authorization pharmacovigilance study. Published online January 18, 2022:2022.01.17.22269263. https://doi.org/10.1101/2022.01.17.22269263
Levy M, Recher M, Hubert H, et al. Multisystem inflammatory syndrome in children by COVID-19 vaccination Status of Adolescents in France. JAMA. 2022;327(3):281–3. https://doi.org/10.1001/jama.2021.23262.
Jain E, Donowitz JR, Aarons E, Marshall BC, Miller MP. Multisystem Inflammatory Syndrome in Children after SARS-CoV-2 Vaccination. Emerg Infect Dis. 2022;28(5):990–3. https://doi.org/10.3201/eid2805.212418.
Yao Q, Waley L, Liou N. Adult presentation of multisystem inflammatory syndrome (MIS) associated with recent COVID-19 infection: lessons learnt in timely diagnosis and management. BMJ Case Rep. 2021;14(10):e243114. https://doi.org/10.1136/bcr-2021-243114.
Patel T, Kelleman M, West Z, et al. Comparison of multisystem inflammatory syndrome in children-related myocarditis, classic viral myocarditis, and COVID-19 vaccine-related myocarditis in children. J Am Heart Assoc. 2022;11(9):e024393. https://doi.org/10.1161/JAHA.121.024393.
Chin SE, Bhavsar SM, Corson A, Ghersin ZJ, Kim HS. Cardiac complications associated with COVID-19, MIS-C, and mRNA COVID-19 Vaccination. Pediatr Cardiol. 2022;43(3):483–8. https://doi.org/10.1007/s00246-022-02851-x.
Rhedin S, Lundholm C, Horne A, et al. Risk factors for multisystem inflammatory syndrome in children - A population-based cohort study of over 2 million children. Lancet Reg Health Eur. 2022;19:100443. https://doi.org/10.1016/j.lanepe.2022.100443.
Zambrano LD, Newhams MM, Olson SM, et al. Effectiveness of BNT162b2 (Pfizer-BioNTech) mRNA Vaccination Against Multisystem Inflammatory Syndrome in Children Among Persons Aged 12–18 Years - United States, July-December 2021. MMWR Morb Mortal Wkly Rep. 2022;71(2):52–8. https://doi.org/10.15585/mmwr.mm7102e1.
Long F, Zhu S, Wang Z, et al. Update on the treatment of multisystem inflammatory syndrome in children associated with COVID-19. Future Virol. 2023;18(1):63–74. https://doi.org/10.2217/fvl-2022-0048.
Mahmoud S, El-Kalliny M, Kotby A, El-Ganzoury M, Fouda E, Ibrahim H. Treatment of MIS-C in Children and Adolescents. Curr Pediatr Rep. 2022;10(1):1–10. https://doi.org/10.1007/s40124-021-00259-4.
Algarni AS, Alamri NM, Khayat NZ, Alabdali RA, Alsubhi RS, Alghamdi SH. Clinical practice guidelines in multisystem inflammatory syndrome (MIS-C) related to COVID-19: a critical review and recommendations. World J Pediatr WJP. 2022;18(2):83–90. https://doi.org/10.1007/s12519-021-00499-w.
Multisystem Inflammatory Syndrome in Children (MIS-C) Interim Guidance. https://www.aap.org/en/pages/2019-novel-coronavirus-covid-19-infections/clinical-guidance/multisystem-inflammatory-syndrome-in-children-mis-c-interim-guidance/. Accessed July 10, 2023